Chinese regulatory authorities have granted Boehringer Ingelheim Vetmedica GmbH market authorization for Ingelvac CircoFLEX, a vaccine against porcine circovirus disease.
Intervet/Schering-Plough Animal Health has received marketing authorization from the European Commission for a single-shot vaccination schedule of its Porcilis vaccine against porcine circovirus type 2 (PCV2) infections.